Nanozymes: a new field bridging nanotechnology and medicine
Joint Research Seminar
|Date and Time||2/1/2023 (Wed) 15:00 ~ 16:00|
|Venue||Auditorium, 1st Building|
|Speaker||Professor Xiyun Yan|
|Affiliation/Position||Member of Chinese Academy of Sciences, Professor & Director, the key Laboratory of Protein Drug in Institute of Biophysics, CAS, Director, the CAS Engineering Laboratory for Nanozyme|
|Title||Nanozymes: a new field bridging nanotechnology and medicine|
Dr. Yan has pioneered the concept of nanozyme, established the standard for the detection of nanozyme catalytic activity, and developed the first commercial nanozyme products for detecting Ebola, COVID-19 and tumors. Following her pioneering work, more than 12000 papers have been published by 400 laboratories across 35 countries describing 1000+ nanozymes utilized in medicine, agriculture and environmental protection. In 2022, the Nanozyme has been selected Top Ten Emerging Technologies in Chemistry by IUPAC and Dr. Yan is in the list of Top-cited Scientists. Also Dr. Yan is a world-renowned expert in tumor biology due to her discovering two novel tumor targets, CD146 and TfR1, for the therapy of melanoma, glioma, and pancreatic cancer, and phase I clinical trials are scheduled for the end of 2022.